PMC:7652766 / 84094-84316 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T122","span":{"begin":156,"end":162},"obj":"Phenotype"}],"attributes":[{"id":"A122","pred":"hp_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"ndividuals’ cells to treat critically ill patients with COVID-19 can be a promising tool.\nThe clinical use of IL-7 has been implemented in the treatment of cancer patients and infectious diseases, mainly with the objective"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3020","span":{"begin":18,"end":20},"obj":"Gene"},{"id":"3030","span":{"begin":42,"end":50},"obj":"Species"},{"id":"3031","span":{"begin":72,"end":73},"obj":"Gene"},{"id":"3036","span":{"begin":27,"end":41},"obj":"Disease"},{"id":"3037","span":{"begin":56,"end":64},"obj":"Disease"},{"id":"3051","span":{"begin":110,"end":114},"obj":"Gene"},{"id":"3057","span":{"begin":163,"end":171},"obj":"Species"},{"id":"3060","span":{"begin":156,"end":162},"obj":"Disease"},{"id":"3061","span":{"begin":176,"end":195},"obj":"Disease"}],"attributes":[{"id":"A3020","pred":"tao:has_database_id","subj":"3020","obj":"Gene:6999"},{"id":"A3030","pred":"tao:has_database_id","subj":"3030","obj":"Tax:9606"},{"id":"A3031","pred":"tao:has_database_id","subj":"3031","obj":"Gene:351"},{"id":"A3036","pred":"tao:has_database_id","subj":"3036","obj":"MESH:D016638"},{"id":"A3037","pred":"tao:has_database_id","subj":"3037","obj":"MESH:C000657245"},{"id":"A3051","pred":"tao:has_database_id","subj":"3051","obj":"Gene:3574"},{"id":"A3057","pred":"tao:has_database_id","subj":"3057","obj":"Tax:9606"},{"id":"A3060","pred":"tao:has_database_id","subj":"3060","obj":"MESH:D009369"},{"id":"A3061","pred":"tao:has_database_id","subj":"3061","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ndividuals’ cells to treat critically ill patients with COVID-19 can be a promising tool.\nThe clinical use of IL-7 has been implemented in the treatment of cancer patients and infectious diseases, mainly with the objective"}